Overview Of Value Stocks In The Basic Materials Sector

The Meaning Behind Value Stocks A value stock is traditionally defined in terms of how investors in the…

The Meaning Behind Value Stocks

A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company’s future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.

The following stocks are considered to be notable value stocks in the basic materials sector:

  1. Algoma Steel Gr (NASDAQ:ASTL) – P/E: 3.85
  2. ICL Group (NYSE:ICL) – P/E: 3.71
  3. Sylvamo (NYSE:SLVM) – P/E: 6.15
  4. Nucor (NYSE:NUE) – P/E: 6.09
  5. Suzano (NYSE:SUZ) – P/E: 2.22

Algoma Steel Gr has reported Q3 earnings per share at $-0.48, which has decreased by 271.43% compared to Q2, which was 0.28. Its most recent dividend yield is at 2.42%, which has decreased by 0.3% from 2.72% in the previous quarter.

ICL Group saw a decrease in earnings per share from 0.49 in Q3 to $0.28 now. Its most recent dividend yield is at 7.21%, which has decreased by 3.91% from 11.12% in the previous quarter.

Sylvamo saw a decrease in earnings per share from 2.51 in Q3 to $1.97 now. Its most recent dividend yield is at 2.14%, which has decreased by 0.2% from 2.34% in the previous quarter.

Most recently, Nucor reported earnings per share at $4.45, whereas in Q4 earnings per share sat at $4.89. Most recently, the company reported a dividend yield of 1.21%, which has decreased by 0.16% from last quarter’s yield of 1.37%.

Suzano saw an increase in earnings per share from 0.79 in Q3 to $1.08 now.

These 5 value stocks were selected by Benzinga Insights based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.

Total
0
Shares
Related Posts
Read More

Sosei Heptares and AbbVie Announced New Multi-target Collaboration to Discover, Develop and Commercialize Novel Medicines Targeting Neurological Diseases; Sosei Heptares Eligible to Receive up to $80M in Upfront, Near-term Milestone Payments; Up to $1….

Sosei Group Corporation ("the Company"; TSE: 4565) and AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, announce they have entered a new drug discovery collaboration and option-to-license agreement to discover, develop and commercialize small molecules that modulate novel G protein-coupled receptor (GPCR)

ABBV